Current Studies
The studies listed here represent a selection of the diagnostic and therapeutic studies offered at the NCRC– Neuroscience Clinical Research Center. In addition to the investigator-initiated studies, we also take part in studies carried out by pharmaceutical companies.
- AON-S: Acute Optic Neuritis Study
- BERLimmun: Berlin Registry of Neuroimmunological Entities
- HOPE-MS: Clinical validity of an episodic self-measurement of motor function to assess disease progression in people with multiple sclerosis
- NEMOS: Database of the Neuromyelitis optica study group
- SecUse: Scientific utilization of data from the already completed studies CIS cohort, ViMS and NMO cohort
- MYA-IN-DEPTH: Myasthenia gravis - In depth-characterization of antibody-specific pathomechanisms at the neuromuscular junction and identification of novel autoantibodies
- MYASTHENIA Cohort: Myasthenia Gravis: diagnostic, prognostic, and therapy response markers
- RWE RavEcu: Treatment satisfaction of myasthenia patients under complement inhibitors in standard clinical care in Germany - a multicenter observational study
- Mya-Keto: Ketogenic diet as a complementary therapy for myasthenia gravis - a randomized controlled trial
- PROGNO-MG: Multicenter study to explore a biomarker (profile) for the future prediction of highly active disease progression in immunotherapy-naïve myasthenia patients
- MG thymectomy: Influence of thymectomy on the course of myasthenia gravis and the role of the surgical procedures